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Type I diabetic patients (DM-1) with an elevated urinary
albumin excretion (UAE430 mg/24 h) have a high cardi-
ovascular risk. However, DM-1 patients with normal UAE
have incipient abnormalities of the cardiovascular and
nervous systems, such as elevations of blood pres-
sures, increases in arterial stiffness and deterioration of
autonomic nervous function. We studied the interrela-
tionships of these abnormalities in normoalbuminuric
DM-1 patients. In 76 patients, we performed two
cardiovascular reflex tests (deep in- and expiration test
(IE test) and lying-to-standing test (LS test)), and
determined aortic pulse wave velocity (PWV), local
arterial compliances of the common carotid, femoral
and brachial arteries, and 24-h blood pressures. The
DRRmax value of the LS test was associated with aortic
PWV (negatively) and the compliance coefficients of the
carotid, femoral and brachial arteries. Per 100-ms
increase in DRRmax, pulse wave velocity decreased by
0.39 m/s, compliance coefficients of the carotid, femoral
and brachial arteries increased by 0.06, 0.08 and
0.05 mm2/kPa, respectively. These associations were
independent of age, 24-h mean arterial pressure and
24-h heart rate. Increases in arterial stiffness were
associated with increases in 24-h systolic and pulse
pressure (per 1 m/s increase in PWV, systolic and pulse
pressure increased by 2.1 and 1.7 mmHg, respectively).
In normoalbuminuric DM-1 patients, deterioration of
autonomic nervous function is associated with an
increase in arterial stiffness, which, in turn, was
associated with, and may cause, increased systolic
and pulse pressure. These findings suggest that
preventive strategies targeting autonomic dysfunction
may reduce cardiovascular morbidity in diabetes.
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Introduction
Type I diabetic (DM-1) patients have an increased
mortality and morbidity risk compared to nondia-
betic subjects. In all, 75% percent of total diabetes-
related mortality is due to cardiovascular disease.1,2
A urinary albumin excretion (UAE) of 30–300 mg/
24 h identifies DM-1 patients with a high risk of
developing end-stage renal disease and of premature
death.3,4 Normoalbuminuric DM-1 patients have a
lower risk of these complications. However, studies
using sophisticated techniques have shown incipi-
ent abnormalities of the cardiovascular and nervous
systems in these patients. These abnormalities
include small elevations of blood pressures, a
decreased blood pressure decline during sleep,
increases in arterial stiffness and impaired auto-
nomic nervous function.5–8 Although these abnorm-
alities might be separate and unrelated
consequences of the hyperglycaemic environment,
it is plausible that abnormalities of the autonomic
nervous system and the cardiovascular system are
interrelated.9–12
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Since incipient abnormalities might be reversible
and thus better accessible for therapeutic interven-
tions, it is important to study early abnormalities
and their mutual interrelationships. Previous stu-
dies have addressed some combinations of early
changes,8,10,13,14 but not extensively. We hypothe-
sized that incipient neuropathy could influence
large artery stiffness by direct effects on large
arteries (through effects on tone, on proliferation of
smooth muscle cells, and on extracellular matrix
composition), as well as by effects on small arteries
and arterioles, which might alter pulse wave reflec-
tion. Changes in large artery stiffness, for their part,
are expected to result in changes in blood pressures,
particularly systolic and pulse pressure.
In view of these considerations, we studied early
abnormalities of the cardiovascular system in nor-
moalbuminuric DM-1 patients. We focused on the
interrelationships among autonomic function, arter-
ial stiffness and arterial blood pressure.
Material and methods
Between January 1994 and January 1996, a cross-
sectional study in DM-1 patients was performed in
the outpatient clinics of the Departments of Medi-
cine of five secondary referral centres: the IJsselland
Ziekenhuis in Capelle aan de IJssel, the Sint Jans-
Gasthuis in Weert, the De Weverziekenhuis in
Heerlen, the Franciscus Ziekenhuis in Roosendaal
and the Sint Franciscus Ziekenhuis in Rotterdam.
Initial results of ambulatory blood pressure mea-
surements in these DM-1 patients have been
published previously.5 DM-1 was defined as onset
of diabetes before the age of 30 and necessity of
insulin therapy within 6 months after the onset of
the disease. Inclusion criteria were: age o65 years;
no pregnancy; body mass index (BMI) o29 kg/m2;
absence of a history of clinical atherosclerotic
disease; serum creatinine o120 mmol/l; UAE
o30 mg/24 h; serum total cholesterol o8 mmol/l
and no treatment with antihypertensive drugs. The
protocol had been approved by the appropriate
medical ethics committees. All included DM-1
patients gave informed consent.
Serum creatinine and cholesterol were deter-
mined by routine methods. UAE was determined
by use of an immunoturbidimetric technique (Behr-
ing, Germany), the median of three 24-h urine
collections was used. HbA1c was determined with
a high-pressure liquid chromatography technique
(normal range, 3.4–6.5%).
Autonomic nervous function
Autonomic function tests were performed before the
start of the ambulatory blood pressure monitoring
(ABPM). Autonomic function was estimated from
two cardiovascular reflex tests: the heart rate
variability during deep breathing and the lying-to-
standing (LS) test.15 Execution of these tests and
analysis of heart rate variability (HRV) have been
described previously.5 In brief, the deep in- and
expiration test (IE test) determines the maximal
difference in duration of the RR interval of the ECG
during deep inspiration and expiration, and is
considered to be an estimate of parasympathetic
nervous function. The LS test quantifies first the
initial increase in heart rate after standing up by
determining the shortening of the RR interval
(DRRmax (ms)) of the ECG after this manoeuvre;
second, it determines the ratio of the duration of the
longest RR interval around the 30th and the shortest
RR interval around the 15th heart beat after standing
up (RRmax/RRmin ratio or max/min ratio). The
DRRmax value reflects both parasympathetic and
sympathetic nervous function, whereas the max/
min ratio is determined largely by the peripheral
sympathetic nervous function. Classification of
normal, borderline or abnormal was carried out
using the age-adjusted reference values of Wieling
et al.16
Determination of arterial stiffness
All subjects refrained from smoking or consuming
caffeine for at least 2 h before examination. After
15 min of supine rest in a quiet room with constant
temperature of 221C, aortic, right carotid, right
femoral and right brachial artery wall properties
were measured with a vessel wall movement
detector system.17 This device accurately measures
diastolic diameter (D) and changes in diameter
during the heart cycle (DD). All measurements were
made by the same observer (JJvdH-S). The mean of
three consecutive measurements (about 15 heart
beats) was taken as the patient’s reading. Carotid,
femoral and brachial arterial compliances were
expressed as a compliance coefficient (CC) and
was defined as the compliance per unit of length
(L), which is the change in cross-sectional area (DA)
per unit of pressure (DP). Likewise, carotid, femoral
and brachial arterial distensibilities were expressed
as distensibility coefficients (DC), defined as the
relative change in cross-sectional area (DA/A) of
the vessel per unit of pressure. Simultaneously with
the vascular measurements, blood pressure was
measured at the left arm, with a semi-automated
device (Dinamap; Critikon, Tampa, FL, USA).
Brachial pulse pressure was calculated as the mean
difference between systolic and diastolic blood
pressures of 15 recordings. Pulse pressures at the
common carotid and femoral arteries were calcu-
lated with a technique that calibrates the distension
curves obtained with echo-tracking, assuming that
the diastolic and mean blood pressures are constant
along the arterial tree. This technique has shown
good accuracy.18 Carotid, femoral and brachial
arterial wall properties were calculated using the
following equations:
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DC ¼ ð2DD  D þ DD2Þ=ðDP  D2Þð103=kPaÞ ð1Þ
CC ¼ pð2D  DD þ DD2Þ=4DPðmm2=kPaÞ ð2Þ
where DP is the local pulse pressure. Distensibility
reflects predominantly the elastic properties of the
arterial wall, while compliance is a measure of the
buffering capacity of the vessel. This method has
shown good reproducibility (coefficients of varia-
tion of the intraobserver variability about 8, 13 and
15% for the carotid, femoral and brachial arteries,
respectively).17
Pulse wave velocity was estimated by the vessel
wall movement detector system by use of the delay
time from the ECG-trigger (R-top) to the 10% level of
the ascending limb of the distension waveform. The
difference between the delay times to the femoral
and the carotid artery was used as an estimate of the
carotid–femoral transit time (T). The mean of three
recordings was taken as the subject’s reading. The
distances from the sternal notch to the site of
measurement of the common carotid artery and
femoral artery were measured with a tape measurer.
The difference between these two distances was
used as an estimate of the length of the carotido-
femoral segment (Lao).
19 The average pulse wave
velocity (PWV) in this segment was calculated as
PWV ¼ Lao=Tðm=sÞ ð3Þ
which is an estimate of the stiffness of mainly the
descending aorta.20 This technique has shown good
reproducibility (intra-observer coefficient of varia-
tion about 14%).21 PWV is related to arterial
distensibility by the formula of Moens–Korteweg:22
PWV ¼ pð1=rDCÞ ð4Þ
where r is the blood density.
Ambulatory blood pressure measurements (ABPM)
ABPM was performed with a SpaceLabs 90207
monitor (Spacelabs Inc., Redmond, Washington,
USA). Ambulatory blood pressure readings were
taken at 15-min intervals from 0700 to 2200 h, and at
20-min intervals from 2200 to 0700 h Results of
blood pressure measurements were not displayed by
the monitor. ABPM was repeated in patients who
had ABPM recordings with more than 25% missing
values or more than two missing consecutive hours.
All mean blood pressures and heart rates (24-h
systolic, 24-h MAP and 24-h diastolic blood pres-
sures, 24-h heart rate and heart rate awake and heart
rate asleep) were calculated from hourly averages.
The waking period was taken from 1000 till 2000 h,
the sleeping period from 0000 to 0600 h (ie, 6 h).
This method provides good estimates of blood
pressures during the waking and sleeping periods,
especially when one has a traditional sleep pattern
(ie going to bed in the evening before 0100 h and
awaking in the morning before 1000 h).23,24 The heart
rate decline during sleep was calculated as the
difference between the mean heart rate during the
waking period (HR awake) and the mean heart rate
during the sleeping period (HR asleep). The relative
heart rate decline was calculated as: relative heart
rate decline (%)¼ (HR awake minus HR
asleep)*100/HR awake. Pulse pressure was defined
as the difference between systolic and diastolic
blood pressures.
Statistical analysis
Patient characteristics are given as means (s.d.) or
percentages. All parameters used in the analyses
normally distributed. We used multiple regression
analyses to study the relationship of estimates of
arterial stiffness with autonomic nervous function.
Aortic PWV and carotid, femoral and brachial artery
CC or DC were included as dependent variables, and
the IE value, DRRmax value or max/min ratio as
independent variables. As both estimates of auto-
nomic nervous function and arterial stiffness are
age-dependent,16,25 all analyses were adjusted for
age. Next, we explored the mechanisms of the
associations (if any) by analysing the associations
of arterial diameter and distension with autonomic
nervous function.
In addition, we investigated whether arterial
stiffness (independent variable) was associated with
(and thus a potential contributor to) ambulatory
systolic and pulse pressure (dependent variables).
These analyses were also adjusted for age.29
All associations were additionally adjusted for
potential confounders, such as 24-h MAP, mean 24-
h heart rate,26,27 pulse pressure, sex, diabetes
duration, body mass index, HbA1c, serum choles-
terol and smoking. All testing was two-sided, with
Po0.05 considered statistically significant. All
statistical analyses were performed with SPSS
11.0.1 for Windows (SPSS Inc., Chicago, IL, USA).
Results
Table 1 shows the patient characteristics.
Autonomic nervous function and arterial stiffness
(Tables 1 and 2)
The IE value and the max/min ratio were not
associated with aortic PWV or carotid, femoral and
brachial DC and CC (P-values40.2), while the
DRRmax value was associated with aortic PWV
and carotid, femoral and brachial CC (Table 2) but
not DC (data not shown). Additional adjustments for
24-h MAP, 24-h heart rate, brachial pulse pressure,
sex, diabetes duration, BMI, HbA1c, serum total
cholesterol and smoking did not importantly affect
these associations (Table 2; data partially shown).
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Associations of DRRmax with diameter were
b¼ 0.07 (P¼ 0.37) for the carotid, b¼ 0.21
(P¼ 0.08) for the femoral, and b¼ 0.20 (P¼ 0.03)
for the brachial artery. Associations of DRRmax with
distension were b¼ 0.02 (P¼ 0.15) for the carotid,
b¼ 0.02 (P¼ 0.12) for the femoral, and b¼ 0.03
(P¼ 0.04) for the brachial artery.
Arterial stiffness and 24-h ambulatory systolic blood
pressure (Table 3)
Linear regression analysis adjusted for age showed
that the CCs of the carotid, femoral and brachial
arteries (independent variables) were not related to
ambulatory systolic blood pressure (data not
shown). In contrast, aortic PWV and the DC of the
carotid artery were significantly related to 24-h
ambulatory systolic blood pressure. After adjusting
for 24-h MAP, the relationship of 24-h systolic blood
pressure with PWV persisted, whereas the relation-
ship with the DC of the carotid artery did not
(Table 3). Relationships among blood pressures and
the DCs of the femoral and brachial arteries were
comparable with those of the DC of the carotid artery
(data not shown).
Additional adjustments for sex, diabetes duration,
BMI, HbA1c, serum total cholesterol and smoking
did not importantly affect these associations (data
not shown).
Arterial stiffness as a determinant of 24-h ambulatory
pulse pressure (Table 4)
Linear regression analysis showed that the CCs of
the carotid, femoral and brachial arteries were not
related to 24-h ambulatory pulse pressures, whereas
the DCs of the femoral and brachial arteries and the
PWV showed statistically significant relationships
with pulse pressure, independently of age. Addi-
tional adjustments for 24-h MAP slightly changed
these relationships (Table 4). Additional adjust-
ments for sex, diabetes duration, BMI, HbA1c,
serum total cholesterol and smoking did not im-
portantly affect these associations (data not shown).
Discussion
This study had two major findings. First, in patients
with otherwise uncomplicated DM-1, impaired
autonomic nervous function was associated with
greater arterial stiffness of the aorta and the carotid,
femoral and brachial arteries. Second, greater arter-
ial stiffness, in turn, was associated with, and may
contribute to, higher systolic and pulse pressure.
Taken together, these data show that these subtle
abnormalities of the cardiovascular system in DM-1
are interrelated and occur before the onset of
microalbuminuria.
The DRRmax value was inversely associated with
aortic PWV and positively with the CCs of the
carotid, femoral and the brachial arteries, after
adjustment for age. This indicates that (incipient)
autonomic dysfunction is associated with an increase
in arterial stiffness. These data are in concordance
with previous studies in DM-1,13,14 which did not
adjust for age. The question arises as to what is
cause and effect: does autonomic dysfunction lead
to increased arterial stiffness, or conversely does
Table 1 Patient characteristics of 76 patients with type 1 diabetes
Number (m/f) 76 (50/26)
Age (years) 32.6 (11.0)
Diabetes duration (years) 14.6 (10.0)
BMI (kg/m2) 24.0 (3.0)
Smoking (yes/no) (N) 24/52
Insulin dose (IU/kg/day) 0.77 (0.20)
Creatinine (mmol/l) 77.4 (10.4)
Cholesterol (mmol/l) 4.7 (1.0)
HbA1c (%) 8.1 (1.4)
UAE (mg/24 h) o 30
Baseline clinical blood pressure
Systolic (mmHg) 123.1 (11.8)
Range/number 4140 mmHg 101 – 164/5
Diastolic (mmHg) 74.1 (7.0)
Range/number 490 mmHg 60 – 93/3
Ambulatory blood pressures
BP 24-h systolic (mmHg) 123.3 (7.6)
BP 24-h MAP (mmHg) 89.9 (5.5)
BP 24-h diastolic (mmHg) 73.9 (5.3)
24-h pulse pressure (mmHg) 49.3 (5.4)
Heart rate 24-h (bpm) 80.6 (9.2)
Vessel wall properties
Common carotid artery
Carotid diameter (mm) 6.96 (0.7)
Carotid distension (mm) 0.57 (0.17)
Carotid compliance (mm2/kPa) 1.03 (0.3)
Carotid distensibility (103/kPa) 28.0 (9.8)
Femoral artery
Femoral diameter (mm) 9.0 (1.1)
Femoral distension (mm) 0.28 (0.12)
Femoral compliance (mm2/kPa) 0.67 (0.3)
Femoral distensibility (103/kPa) 10.9 (6.2)
Brachial artery
Brachial diameter (mm) 3.8 (0.8)
Brachial distension (mm) 0.27 (0.11)
Brachial compliance (mm2/kPa) 0.28 (0.12)
Brachial distensibility (103/kPa) 24.1 (9.4)
Aorta
Pulse wave velocity (m/s) 6.5 (1.8)
Autonomic nervous function
IE value (ms) 247 (139)
Normal/borderline/abnormal IE test (%) 67/7/26
DRRmax (ms) 256 (109)
max/min 1.40 (0.23)
Normal/borderline/abnormal LS test (%) 84/7/9
Data are means (s.d.) or percentages.
BMI¼body mass index; HbA1c¼ glycated haemoglobin; UAE¼urin-
urinary albumin excretion; BP¼ blood pressure; MAP¼mean arterial
pressure; bpm¼ beats per minute; ms¼milliseconds; IE test: deep in-
and expiration test; IE value¼difference in duration of the longest
and shortest RR interval of the ECG during the deep in- and expiration
test; LS test¼ lying-to-standing test; DRRmax¼maximal change in
duration of the RR interval of the ECG after standing up; max/
min¼duration of the longest RR interval around the 30th and the
shortest RR interval around the 15th heart beat after standing up.
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increased arterial stiffness result in impaired auto-
nomic nervous function? On the one hand, greater
aortic and carotid wall stiffness may impair baror-
eceptor (i.e. autonomic) function.28 On the other
hand, cross-sectional studies in DM-1 suggest that
impaired autonomic nervous function occurs con-
siderably earlier than, and therefore may contribute
to, increased arterial stiffness.6,7,9,10 Clearly, prospec-
tive studies are required to resolve this issue.
The mechanisms by which autonomic nervous func-
tion might influence the elastic properties of arteries
cannot be derived from the present study. The
DRRmax value depends both on parasympathetic
and sympathetic nervous function. Parasympathetic
autonomic nervous dysfunction is characterized by
an increase in heart rate, which can already be found
in otherwise uncomplicated DM-1 patients.5,29 In-
creases in heart rate per se result in stiffening of
arteries independently of changes in activity of the
autonomic nervous system.26,27 The relationship
between the DRRmax value and the carotid and
femoral compliance coefficients appeared partly to
be mediated by the heart rate. However, the relation-
ships among the DRRmax value and aortic PWV, and
the CC of the brachial artery were not mediated by
heart rate.
Table 2 Autonomic nervous function as a determinant of aortic PWV and the compliance coefficients of the common carotid, femoral
and brachial arteries
Dependent variable Independent variable b P Adjusted R2 P
Aortic pulse wave velocity (m/s)
DRRmax (per 100 ms)
Model 1 0.39 (0.14) 0.006 0.57 o0.0001
Model 2 0.35 (0.14) 0.014 0.58 o0.0001
Model 3 0.32 (0.15) 0.040 0.58 o0.0001
Compliance coefficient of the common carotid artery (mm2/kPa)
DRRmax (per 100 ms)
Model 1 0.060 (0.028) 0.037 0.33 o0.0001
Model 2 0.054 (0.028) 0.060 0.34 o0.0001
Model 3 0.039 (0.031) 0.211 0.34 o0.0001
Compliance coefficient of the femoral artery (mm2/kPa)
DRRmax (per 100 ms)
Model 1 0.080 (0.037) 0.035 0.04 0.080
Model 2 0.079 (0.038) 0.040 0.03 0.171
Model 3 0.068 (0.041) 0.105 0.02 0.243
Compliance coefficient of the brachial artery (mm2/kPa)
DRRmax (per 100 ms)
Model 1 0.045 (0.013) 0.001 0.14 0.002
Model 2 0.041 (0.013) 0.002 0.16 0.001
Model 3 0.041 (0.014) 0.004 0.15 0.004
Multiple regression analysis with aortic pulse wave velocity and the compliance coefficients as dependent variables. Model 1 was adjusted for
age, model 2 for age and 24-h MAP, and model 3 for age, 24-h MAP, 24-h heart rate. b¼ regression coefficient (standard error of mean);
DRRmax¼ change in duration of the RR interval of the ECG after standing up; MAP¼mean arterial pressure. A regression coefficient of 0.39
(top left) indicates that per 100-ms increase in DRRmax, pulse wave velocity decreased by 0.39 m/s.
Table 3 Multiple linear regression with aortic pulse wave velocity or the distensibility coefficient of the common carotid artery as a
determinant of systolic blood pressure
Dependent variable Independent variable b P Adjusted R2 P
24-h systolic pressure (mmHg)
Pulse wave velocity (m/s)
Model 1 2.08 (0.64) 0.002 0.15 0.001
Model 2 0.81 (0.35) 0.021 0.77 o0.001
Model 3 0.92 (0.34) 0.009 0.77 o0.001
24-h systolic pressure (mmHg)
DC carotid artery (103/kPa)
Model 1 0.30 (0.13) 0.026 0.09 0.013
Model 2 0.04 (0.07) 0.616 0.75 o0.001
Model 3 0.05 (0.07) 0.522 0.76 o0.001
b¼ regression coefficient (standard error of mean); models as defined in Table 2.
Cardiovascular changes in normoalbuminuric type 1 diabetes
FJ van Ittersum et al
765
Journal of Human Hypertension
Blood vessels are abundantly innervated by
sympathetic nerves. To the extent that a decreased
DRRmax value is a consequence of sympathetic
nervous dysfunction, the relationships observed
might be caused by effects of the sympathetic
nervous system on the vascular tone of large arteries.
In rats and humans, most studies show that
sympathetic activity restrains arterial distensibil-
ity.27,30–32 However, in humans the opposite has also
been reported.32,33,33 In addition, these studies
addressed acute modulations of the sympathetic
nervous system, whereas in DM-1 patients chronic
effects are observed. An acute sympathetic denerva-
tion will initially lead to dilation and thus an
increase in diameter of large arteries. However, after
days to weeks the original tone of the smooth muscle
cells will be restored to some extent.34 Whether this
development of intrinsic smooth muscle tone will
finally mimic the original situation or whether it
stabilizes on a lower or higher level is not known.31
Analysis of the relationships among autonomic
function and the arterial diameter and distension
in the present study did not show statistically
significant relationships. We hypothesize that the
autonomic nervous system exerts its effects on
arterial stiffness by influencing both the arterial
diameter and the elastic properties of the vessel
wall. These issues require further study.
Blood pressure and arterial stiffness are interre-
lated.25 In DM-1 patients, an increase in mean blood
pressure is associated with decreased arterial com-
pliance and distensibility coefficients.35 However,
an increase in arterial stiffness will lead to a
decrease of the distension of the artery during the
systole and thereby to an increase in systolic blood
pressure. The present study confirms this concept
by showing that aortic PWV is positively and the
carotid, femoral and brachial DCs are negatively
associated with 24-h systolic arterial blood pressure,
and that much of these associations could not be
explained by variability in 24-h MAP.
In DM-1, an increase in aortic stiffness due to
changes in the extracellular matrix is plausible,
since the increased formation of advanced glycation
products in DM-1 is associated with endothelial
dysfunction and diminished arterial elasticity.36,37
Such changes depend on age and long-term glycae-
mic control. A new finding of the present study is
that autonomic nervous dysfunction may also con-
tribute to increases in arterial stiffness, and that this
is independent of age, diabetes duration, HbA1c and
mean arterial blood pressure.38 In turn, an increase
in arterial stiffness leads to elevations of systolic and
pulse pressures (Tables 3 and 4). These findings
were most obvious when aortic PWV was taken as a
measure of arterial stiffness, possibly due to the fact
that the main buffering capacity of the arterial
system is provided by the aorta, the elastic proper-
ties of which are the main determinants of the
PWV.39
In conclusion, in otherwise uncomplicated DM-1,
impaired autonomic nervous function is associated
with greater arterial stiffness of the aorta and the
carotid, femoral and brachial arteries. These effects
appeared partly mediated by the increase in heart
rate due to (incipient) parasympathetic nervous
dysfunction, and are not explained by glycaemic
control and diabetes duration. Increased arterial
Table 4 Multiple regression analysis of estimates of arterial stiffness as a determinant of pulse pressure
Dependent variable Independent variable b P Adjusted R2 P
24-h pulse pressure (mmHg)
Pulse wave velocity (m/s)
Model 1 1.69 (0.46) o0.001 0.14 0.002
Model 2 1.46 (0.47) 0.003 0.17 0.001
Model 3 1.60 (0.47) 0.001 0.19 0.001
24-h pulse pressure (mmHg)
DC carotid artery (103/kPa)
Model 1 0.12 (0.10) 0.209 0.00 0.354
Model 2 0.06 (0.10) 0.527 0.06 0.057
Model 3 0.07 (0.10) 0.454 0.07 0.059
24-h pulse pressure (mmHg)
DC femoral artery (103/kPa)
Model 1 0.32 (0.10) 0.002 0.10 0.007
Model 2 0.30 (0.10) 0.002 0.17 0.001
Model 3 0.30 (0.10) 0.002 0.18 0.001
24-h pulse pressure (mmHg)
DC brachial artery (103/kPa)
Model 1 0.15 (0.07) 0.037 0.04 0.081
Model 2 0.10 (0.07) 0.169 0.11 0.011
Model 3 0.10 (0.07) 0.176 0.12 0.014
b¼ regression coefficient (standard error of mean); models defined as in Table 2.
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stiffness, in turn, was associated with, and may
cause, increased systolic blood pressure and pulse
pressure. We hypothesize that additional mechan-
isms by which the autonomic nervous system exerts
its effects on the vessel wall include alterations in
vascular tone and the composition of the extracel-
lular matrix of the arteries. Further studies should
address the causes of deterioration of autonomic
nervous function in diabetes, the mechanisms by
which the autonomic nervous system influences
arterial stiffness and strategies to prevent these
abnormalities.
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